Skip to content

Q Therapeutics, Inc.

company.status.inactive

CIK 1366541fmd_0B7QZPCRQ2HDZXFXGV7GJDB9KEManufacturing · Pharmaceutical PreparationsTemplate: Standard

Coverage: Jun 01, 2006 to Sep 30, 2015, 28 periods

Latest annual · FY2014

Millions
Total revenues
1
Gross profit
1
Operating income
(3)
Net income
(3)

Latest quarter · Q3 FY2015

Millions
Operating income
(1)
Net income
(1)
Free cash flow
(0)
Open Financials

Key stats

Open Analysis

Compound annual growth

Revenue, 3 yearsFY2011 to FY2014
+57.4%
Revenue, 5 yearsFY2009 to FY2014
n/m
Net income, 5 yearsFY2009 to FY2014
n/m

Q Therapeutics, Inc. financials: quick answers

Annual figures as filed with the SEC. Each number links to the filing it came from and to its proof.

MetricFY2014FY2013ChangeSource
Revenue$680,264$26,175+2,498.9%10-K 2015-03-31 · proof
Gross profit$679,464$21,375+3,078.8%10-K 2015-03-31 · proof
Operating income-$3.4 million-$3.2 million10-K 2015-03-31 · proof
Net income-$3.4 million-$3.4 million10-K 2015-03-31 · proof
Cash from operating activities-$1.5 million-$877,87310-K 2015-03-31 · proof
Free cash flow-$1.5 million-$901,67510-K 2015-03-31 · proof
Total assets$748,311$257,042+191.1%10-K 2015-03-31 · proof
Total liabilities$1 million$3.3 million-68.4%10-Q 2015-11-13 · proof
Cash and cash equivalents$707,011$142,532+396%10-K 2015-03-31 · proof
What was Q Therapeutics, Inc.'s revenue in fiscal 2014?
Q Therapeutics, Inc. reported revenue of $680,264 for fiscal 2014 (the year ended Dec 31, 2014), against $26,175 the year before (+2,498.9%). Source: the 10-K filed with the SEC on Mar 31, 2015. SEC
What was Q Therapeutics, Inc.'s gross profit in fiscal 2014?
Q Therapeutics, Inc. reported gross profit of $679,464 for fiscal 2014 (the year ended Dec 31, 2014), against $21,375 the year before (+3,078.8%). Source: the 10-K filed with the SEC on Mar 31, 2015. SEC
What was Q Therapeutics, Inc.'s operating income in fiscal 2014?
Q Therapeutics, Inc. reported operating income of -$3.4 million for fiscal 2014 (the year ended Dec 31, 2014), against -$3.2 million the year before. Source: the 10-K filed with the SEC on Mar 31, 2015. SEC
What was Q Therapeutics, Inc.'s net income in fiscal 2014?
Q Therapeutics, Inc. reported net income of -$3.4 million for fiscal 2014 (the year ended Dec 31, 2014), against -$3.4 million the year before. Source: the 10-K filed with the SEC on Mar 31, 2015. SEC
What was Q Therapeutics, Inc.'s cash from operating activities in fiscal 2014?
Q Therapeutics, Inc. reported cash from operating activities of -$1.5 million for fiscal 2014 (the year ended Dec 31, 2014), against -$877,873 the year before. Source: the 10-K filed with the SEC on Mar 31, 2015. SEC
What was Q Therapeutics, Inc.'s free cash flow in fiscal 2014?
Q Therapeutics, Inc. reported free cash flow of -$1.5 million for fiscal 2014 (the year ended Dec 31, 2014), against -$901,675 the year before. Source: the 10-K filed with the SEC on Mar 31, 2015. SEC
What are Q Therapeutics, Inc.'s total assets?
As of Dec 31, 2014, Q Therapeutics, Inc. reported total assets of $748,311, against $257,042 a year earlier (+191.1%). Source: the 10-K filed with the SEC on Mar 31, 2015. SEC
What are Q Therapeutics, Inc.'s total liabilities?
As of Dec 31, 2014, Q Therapeutics, Inc. reported total liabilities of $1 million, against $3.3 million a year earlier (-68.4%). Source: the 10-Q filed with the SEC on Nov 13, 2015. SEC
What are Q Therapeutics, Inc.'s cash and cash equivalents?
As of Dec 31, 2014, Q Therapeutics, Inc. reported cash and cash equivalents of $707,011, against $142,532 a year earlier (+396%). Source: the 10-K filed with the SEC on Mar 31, 2015. SEC

Read from the FinancialMD API on Nov 13, 2026. Values change only when a new filing is made; see the Financials tab for every period and as-of replay.

The same numbers for an agent, with proof on every value:

curl "https://api.financial.md/v1/company/financials/income_statement/standardized?company=cik:1366541&period_type=annual&limit=5"

Information only, not investment advice.